Germany Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Germany Clinical Nutrition for Diabetes Care Market Analysis

$ 3999

The Germany Clinical Nutrition for Diabetes Care Market was valued at $78.69 Mn in 2023 and is predicted to grow at a CAGR of 2.98% from 2023 to 2030, to $96.65 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Fresenius Kabi, Baxter International, and Novo Nordisk among others.

ID: IN10DEPH566 CATEGORY: Pharmaceuticals GEOGRAPHY: Germany AUTHOR: Avantika Gupta

Buy Now

Germany Clinical Nutrition for Diabetes Care Market Executive Summary

The German Clinical Nutrition for Diabetes Care Market is at around $78.69 Mn in 2023 and is projected to reach $96.65 Mn in 2030, exhibiting a CAGR of 2.98% during the forecast period.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It involves using evidence-based nutrition treatment to help diabetic patients maintain blood sugar control, avoid complications, and enhance their overall metabolic health. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and enhance overall health outcomes for those with diabetes.

The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation, as reported by the WHO.

The leading pharmaceutical companies include Fresenius Kabi, Nestlé Health Science is known for its extensive portfolio of medications, including those essential for diabetes care. Baxter International, Abbott Diabetes Care, and Roche Diabetes Care are also significant contributors to the Clinical Nutrition for Diabetes Care landscape, with continuous research and development activities.

Germany Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Increasing Prevalence of Diabetes: In recent years, diabetes has been on the rise worldwide, primarily due to factors like inactive behaviors, poor dietary choices, and increasing levels of obesity. Germany has a higher diabetes rate in comparison to numerous other nations. According to the International Diabetes Federation, roughly 16.9% of Mexican adults are living with diabetes. Recognition of the importance of nutrition therapy in treating diabetes is growing, as is the understanding of how clinical nutrition services and products can enhance patient results.

High-Quality Diabetes Care Infrastructure: Healthcare facilities in Germany are known for their high-quality treatment of diabetes-related complications. They prioritize conservative treatments and utilize advanced diagnostic techniques and personalized nutrition approaches to enable early identification and management of diabetes complications, improving patient prognosis.

Personalized Nutrition Solutions: The clinical nutrition market in Germany is moving towards more personalized and tailored approaches, leveraging advancements in nutrigenomics and data analytics. These solutions aim to develop customized nutritional interventions based on an individual's genetic profile, disease state, and lifestyle factors, enabling more effective management of diabetes.

Initiatives for diabetes management: The German government has developed a National Diabetes Strategy (Nationale Diabetes Strategy) to address the growing prevalence of diabetes and its associated complications. The strategy focuses on prevention, early detection, treatment, and management of diabetes across different sectors of healthcare. DiGA (Digital Health Applications) involves the integration of approved digital health apps into standard care, focusing on diabetes management.

Market Restraints

High Cost: Specialized nutritional products like enteral formulas or medical foods are expensive compared to regular groceries. The higher cost may pose affordability challenges for some patients, especially those without adequate insurance coverage or financial support, restricting market penetration.

Competing Health Priorities: In a resource-constrained setting, diabetes may not always be the top health priority, with other chronic diseases often receiving more attention and funding. This can limit the allocation of resources for clinical nutrition in diabetes care.

Limited awareness and education: There is a need to increase awareness about the importance of proper nutrition in diabetes management among both patients and healthcare providers in Germany. Lack of education can hinder the utilization of clinical nutrition therapies.

Regulatory Landscape and Reimbursement Scenario

Federal Ministry of Food and Agriculture (BMEL) sets general regulations for food safety and labeling through laws like the German Food and Feed Law (Lebensmittel-, Futtermittel-, und Bedarfsgegenständegesetz - LFGB). This ensures basic safety standards for all food products, including those consumed by diabetics.

European Food Safety Authority (EFSA) is responsible for assessing the safety and efficacy of food additives, novel foods (including some specialized diabetic products), and nutritional claims. German Diabetes Association (Deutsche Diabetes Gesellschaft - DDG): Develops clinical practice guidelines for diabetes management, which may include recommendations for incorporating clinical nutrition into patient care plans.

There are certain oral nutritional supplements or meal replacements that might be categorized as "Dietary Aids" (diätetische Lebensmittel). Reimbursement for these is generally limited and depends on the individual health insurance plan. Private health insurance might offer more coverage for these products. The reimbursement of individual dietary counseling by statutory health insurance (SHI) companies is often inconsistent and requires significant bureaucratic effort to enforce.

Competitive Landscape

Key Players

Here are some of the major key players in the Germany Clinical Nutrition for Diabetes Care Market:

Fresenius Kabi
B. Braun Melsungen
Bayer Diabetes Care
Nestlé Health Science
Roche Diabetes Care
Abbott Nutrition
Sanofi
Dr. Wolz GmbH
Baxter International
Novo Nordisk

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Germany Clinical Nutrition for Diabetes Care Market Segmentation

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feedback Formulas

By Stage

Adult
Paediatric

By Distribution Channel

Online
Retail
Institutional Sales

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.